Abstract:A 28-year-old woman presented with a 16-year history of recurrent pruritic dry lesions that began on her forehead and spread. She had been diagnosed with atopic dermatitis and reported a history of allergic rhinitis. Her mother had xerosis and dust allergy. A physical examination revealed skin xerosis, multiple discrete erythematous plaques covered with fine non-adherent scales involving 50% of the body surface and total hair loss (Fig. 1) Enlarged lymph nodes in neck, axillae, and groin were palpated. The laboratory results revealed peripheral eosinophils granulocytes at 0.81 9 10/L and serum immunoglobulin E 35 798.0 IU/ mL. Skin biopsies taken from the scalp and forehead showed atypical lymphoid infiltrate involving the dermis and hair follicles with focal epidermotropism. An immunohistochemical analysis revealed neoplastic infiltrate strongly positive for CD2, CD3, CD4, and CD5, and negative for CD8, CD56, CD79a, granzyme (Fig. 2). The value of the Ki-67 index was about 10%. The analysis of the Tcell receptor b-chain gene rearrangement revealed a monoclonal population of T-cells. No evidence of bone marrow or cervical lymph node involvement was documented. We diagnosed folliculotropic mycosis fungoides (FMF) stage T2N1M0B0, clinical stage IIa. We combined systemic prednisone 25 mg/day, interferon alpha-2b at 6 mIU/week, methotrexate 15 mg/week and topical 20% nitrogen mustard, which achieved mild improvement, except for alopecia. After 18-months’ follow up, the patient had not experienced a complete response. Folliculotropic mycosis fungoides is a rare variant of primary cutaneous T-cell lymphoma. FMF represents less than 10% of mycosis fungoides cases. It is more prevalent in adult men. FMF frequently appears as follicular papules and alopecia, but also as indurated plaques, acneiform lesions or follicular keratosis–pilaris-like lesions. Pruritus is present in 81% of cases. It has a predilection for the head and neck, in contrast to the common bathing suit distribution of conventional mycosis fungoides. In onethird of patients the eyebrows are affected with follicular accentuation or alopecia. Because of infiltration of the lymphoma cells that show folliculotropism, it has a more aggressive course and resistance to treatments than other mycosis fungoides variants. The number of mycosis fungoides cases with a history of atopic dermatitis has increased in the last decade. The mechanisms for this association have not been elucidated. Factors that are common in both illnesses include the crucial role of CD4+ T-cells, an analogue cytokine background, the potential role of immunoglobulin E antibodies, and persistent antigenic stimulation by bacteria that may modify T-cell functionality, resulting in proliferation and malignant transformation. Currently, no standard treatment exists for FMF. The therapeutic reaction of our patient is in accord with the known resistance to standard treatments. The authors believe that the coexistence of these two entities has not occurred by chance. Hence we urge

Mycosis fungoides: Current trends in diagnosis and management

When mycosis fungoides seems not to be within the spectrum of clinical and histopathological differential diagnoses

P068 A history of mycosis fungoides: from Alibert to mogamulizumab

Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management

Systemic involvement in mycosis fungoides

Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management

H03 (P068) A history of mycosis fungoides: from Alibert to mogamulizumab

Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management

Phototherapy and mycosis fungoides: what's new?

Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides

Skin-directed therapy and biologic response modifiers in mycosis fungoides

A Man with Worsening Scaling Plaques and a New Onset Large Draining Ulcerated Tumor

Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides

Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments

The Role of microRNA in Pathogenesis, Diagnosis, Different Variants, Treatment and Prognosis of Mycosis Fungoides

Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers

Folliculotropic mycosis fungoides associated with atopic dermatitis

Transcriptomic changes during stage progression of mycosis fungoides

Mycosis Fungoides Staged By F-18-Flurodeoxyglucose Positron Emission Tomography/Computed Tomography Case Report And Review Of Literature

Granulomatous mycosis fungoides: A difficult diagnosis!

A Comprehensive Study on Aberrant CD20-Positive Mycosis Fungoides: Clinical and Prognostic Insights